Essex Investment Management CO LLC T2 Biosystems, Inc. Transaction History

Essex Investment Management CO LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$0.96 - $2.94 $318,863 - $976,518	-332,149 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$0.58 - $3.01 $192,646 - $999,768	332,149 New	332,149 $830,000
Q2 2019 Aug 15, 2019	SELL	$1.47 - $3.16 $294,000 - $632,000	-200,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.56 - $4.48 $373,135 - $652,986	-145,756 Reduced 42.16%	200,000 $526,000
Q4 2018 Feb 06, 2019	SELL	$2.98 - $6.86 $988,397 - $2.28 Million	-331,677 Reduced 48.96%	345,756 $1.04 Million

Q3 2018 Oct 16, 2018	SELL	$5.36 - $7.83 $9,471 - $13,835	-1,767 Reduced 0.26%	677,433 $5.05 Million
Q2 2018 Jul 17, 2018	BUY	$5.97 - $9.58 $121,376 - $194,770	20,331 Added 3.09%	679,200 $5.26 Million
Q1 2018 Apr 26, 2018	SELL	$4.21 - $7.0 $101,583 - $168,903	-24,129 Reduced 3.53%	658,869 $4.28 Million
Q4 2017 Feb 05, 2018	SELL	$3.73 - $4.6 $86,521 - $106,701	-23,196 Reduced 3.28%	682,998 $2.81 Million
Q3 2017 Oct 30, 2017	BUY	$3.9 - $6.78 $2.75 Million - $4.79 Million	706,194	706,194 $2.97 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $35.6M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.